Monoclonal Antibodies in Relapsed Multiple Myeloma with Cristina Gasparetto, MD: Case 2

Monoclonal Antibodies in Relapsed Multiple Myeloma with Cristina Gasparetto, MD

Case Scenario 2:

January 2015

  • The patient is a 72-year old female who was diagnosed with ISS stage I multiple myeloma.
  • She is an insulin dependent diabetic who is experiencing peripheral neuropathy.
  • Her cytogenetics were classified as standard risk.
  • Performance status 1.
  • She received treatment with lenalidomide (25 mg daily) and low-dose dexamethasone with a good response.
  • After a year she decided to come off of lenalidomide therapy.

     July 2016

  • Six months after stopping therapy, the patient had increasing fatigue and weakness.
  • CT scan revealed several bone lesions.
  • Patient was started on daratumumab, lenalidomide and dexamethasone
Related Videos
Hope Rugo, MD, FASCO, an expert on breast cancer
Hope Rugo, MD, FASCO, an expert on breast cancer
Hope Rugo, MD, FASCO, an expert on breast cancer
Hope Rugo, MD, FASCO, an expert on breast cancer
Hope Rugo, MD, FASCO, an expert on breast cancer
Hope Rugo, MD, FASCO, an expert on breast cancer
Yi-Bin Chen, MD, an expert on GVHD
Yi-Bin Chen, MD, an expert on GVHD
Related Content